Recursion Pharmaceuticals, Inc. (RXRX)
3.20
+0.04
(+1.27%)
USD |
NASDAQ |
Sep 11, 16:00
3.20
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Price : 3.20 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 3.21 | 3.25 | 3.15 | 3.20 | 8.034M |
| Sep 10, 2026 | 3.14 | 3.25 | 3.10 | 3.16 | 10.63M |
| Sep 09, 2026 | 3.42 | 3.45 | 3.21 | 3.215 | 14.20M |
| Sep 08, 2026 | 3.58 | 3.59 | 3.43 | 3.44 | 14.99M |
| Sep 04, 2026 | 3.415 | 3.70 | 3.41 | 3.63 | 29.04M |
| Sep 03, 2026 | 3.435 | 3.45 | 3.290 | 3.44 | 13.75M |
| Sep 02, 2026 | 3.34 | 3.489 | 3.285 | 3.38 | 14.05M |
| Sep 01, 2026 | 3.34 | 3.38 | 3.280 | 3.33 | 9.997M |
| Aug 31, 2026 | 3.305 | 3.41 | 3.25 | 3.40 | 13.91M |
| Aug 28, 2026 | 3.40 | 3.45 | 3.31 | 3.34 | 10.56M |
| Aug 27, 2026 | 3.515 | 3.550 | 3.42 | 3.44 | 10.99M |
| Aug 26, 2026 | 3.51 | 3.55 | 3.43 | 3.49 | 12.98M |
| Aug 25, 2026 | 3.27 | 3.59 | 3.26 | 3.56 | 22.52M |
| Aug 24, 2026 | 3.42 | 3.44 | 3.215 | 3.25 | 15.16M |
| Aug 21, 2026 | 3.39 | 3.630 | 3.37 | 3.50 | 22.90M |
| Aug 20, 2026 | 3.40 | 3.46 | 3.27 | 3.34 | 21.45M |
| Aug 19, 2026 | 3.275 | 3.50 | 3.19 | 3.50 | 30.37M |
| Aug 18, 2026 | 3.03 | 3.10 | 2.92 | 3.09 | 16.35M |
| Aug 17, 2026 | 3.12 | 3.16 | 3.08 | 3.11 | 10.62M |
| Aug 14, 2026 | 3.30 | 3.305 | 3.14 | 3.16 | 10.55M |
| Aug 13, 2026 | 3.31 | 3.35 | 3.27 | 3.31 | 10.70M |
| Aug 12, 2026 | 3.37 | 3.38 | 3.26 | 3.29 | 10.31M |
| Aug 11, 2026 | 3.32 | 3.42 | 3.27 | 3.35 | 11.01M |
| Aug 10, 2026 | 3.20 | 3.36 | 3.19 | 3.29 | 14.03M |
| Aug 07, 2026 | 3.254 | 3.265 | 3.18 | 3.22 | 9.356M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Twist Bioscience Corp. | 127.22 |
| Absci Corp. | 8.21 |
| Novavax, Inc. | 9.42 |
| Editas Medicine, Inc. | 2.70 |
| Amgen, Inc. | 377.35 |
Price Related Metrics
| PS Ratio | 29.69 |
| Price to Book Value | 1.868 |
| Earnings Yield | -32.38% |
| Market Cap | 1.709B |